Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of July 6th – 12th, 2020.
Without further ado, let’s get started.
* Yahoo Finance readers, please click here to view full article.
10. TCI Insider Trading Report: Top Cannabis Stocks with Recent Insider Trading Activity
Staying up to date on insider trading activity is essential and many investors use this information to help predict the future trend of a sector or an individual stock. Without further delay, here’s a recap of the past month’s insider trading activity from the most noteworthy Cannabis Stocks.
READ FULL TCI INSIDER TRADING REPORT
Companies working in the Psychedelics industry have also listed on the TSX Venture Exchange and the NEO Exchange in Canada. Several other companies in the sector are actively raising capital from the investment community to develop their business, and have plans to “go public” in Canada.
READ FULL PSYCHEDELICS SECTOR ARTICLE
8. Horizons ETFs Rebalances Marijuana-Focused Index ETF Suite
Horizons ETFs Management (Canada) has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF HMMJ and the Horizons U.S. Marijuana Index ETF HMUS.
READ FULL CANNABIS ETFS ARTICLE
7. Aleafia Completes Outdoor Planting on 66 Acres
It Appears That Poor Sector Tailwinds Have Yet to Slow Down Aleafia and its Cultivation Plans
Aleafia Health ALEAF issued a corporate update announcing that they had completed the planting of their outdoor crop, while simultaneously scaling up their greenhouse operations.
6. MagicMed Industries Files First Psychedelic Derivative Patent
MagicMed Industries announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) covering composition of matter, drug formulation and process of preparation claims for novel Psilocybin derivatives.
5. Cansortium Has Turned a Corner, Says Paradigm Capital
Cansortium CNTMF is a medical cannabis company with vertically integrated cultivation, processing, formulation and sales through its patient platform, with operations based in Florida’s medical market but also with interests in Texas, Michigan and Pennsylvania.
ATAI is a Global Biotechnology Company Builder That Envisions an End to Mental Illnesses
ATAI Life Sciences has acquired a majority stake in New York-based pharmaceutical company Kures, which targets the important intersection between pain and opioid use disorder. Additionally, Srinivas Rao, MD, PhD, Chief Scientific Officer of ATAI Life Sciences, has been appointed CEO of Kures.
3.Green Thumb Industries is a Top Pick for Q3, Says Echelon
Echelon Analyst Andrew Semple Renewed GTII’s Status as a Top Pick in a Report to Clients
Semple has put Green Thumb GTBIF into Echelon’s Top Picks Portfolio for the last three quarters, where the stock outperformed the tracking group average for all those time periods, including for the Q2 where GTII returned a massive 65%.
CannaGlobal, Sansero Life Sciences, and Rise Wellness announced the creation of CannaGlobal Wellness, a global Psychedelics leader focused on Psilocybin and other natural compounds to promote emotional, mental, and physical wellness.
1. 3 Reasons Why It’s the Right Time to Buy Trulieve Cannabis
When it comes to cannabis in Florida, Trulieve is the company that comes to mind. There are, of course, other players in the state, but Trulieve Cannabis TCNNF has captured a good chunk of the retail space with 51 dispensaries. The company now operates a total of 53 dispensaries in the U.S., with the other two in California and Connecticut.
Photo by Rick Proctor on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.